Patents by Inventor Jeffrey Knittel

Jeffrey Knittel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified live vaccine of , methods of producing modified live vaccines, combination vaccines and methods of treatment
    Patent number: 9339533
    Abstract: The present invention relates to new attenuated M. bovis bacteria strains passaged at least 110 times. Moreover, the present invention also provides immunogenic compositions comprising live bacteria of any of those attenuated M. bovis bacteria strain, their manufacture and use for the treatment and prophylaxis of M. bovis infections and combinations with other veterinary vaccines or medicaments.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: May 17, 2016
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Michael Beck, Jeffrey Knittel
  • vaccine and methods of use thereof
    Patent number: 8652481
    Abstract: The present invention relates to new attenuated M. bovis bacteria strains. Moreover, the present invention also provides immunogenic compositions comprising live bacteria of an of those attenuated M. bovis bacteria strain, their manufacture and use for the treatment and prophylaxis of M. bovis infections.
    Type: Grant
    Filed: October 29, 2008
    Date of Patent: February 18, 2014
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Michael Beck, Jeffrey Knittel
  • MODIFIED LIVE VACCINE OF MYCOPLASMA BOVIS, METHODS OF PRODUCING MODIFIED LIVE MYCOPLASMA BOVIS VACCINES, COMBINATION VACCINES AND METHODS OF TREATMENT
    Publication number: 20100272759
    Abstract: The present invention relates to new attenuated M. bovis bacteria strains passaged at least 110 times. Moreover, the present invention also provides immunogenic compositions comprising live bacteria of any of those attenuated M. bovis bacteria strain, their manufacture and use for the treatment and prophylaxis of M. bovis infections and combinations with other veterinary vaccines or medicaments.
    Type: Application
    Filed: April 23, 2010
    Publication date: October 28, 2010
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Michael BECK, Jeffrey KNITTEL
  • MYCOPLASMA BOVIS VACCINE AND METHODS OF USE THEREOF
    Publication number: 20090130148
    Abstract: The present invention relates to new attenuated M. bovis bacteria strains. Moreover, the present invention also provides immunogenic compositions comprising live bacteria of an of those attenuated M. bovis bacteria strain, their manufacture and use for the treatment and prophylaxis of M. bovis infections.
    Type: Application
    Filed: October 29, 2008
    Publication date: May 21, 2009
    Applicant: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Michael Beck, Jeffrey Knittel
  • COMBINATION VACCINE COMPRISING AN ATTENUATED BOVINE VIRAL DIARRHEA VIRUS
    Publication number: 20090068223
    Abstract: The present invention relates to combination vaccines for the prophylaxis and treatment of microbiological infections in cattle which comprise an attenuated bovine viral diarrhea virus (BVDV) for the prophylaxis and treatment of BVDV caused infections, and a further immunological active component for the prophylaxis and treatment of microbiological infections other than BVDV.
    Type: Application
    Filed: November 13, 2006
    Publication date: March 12, 2009
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Gregor Meyers, Jeffrey Knittel, Knut Elbers, Rob Tremblay, Craig Jones
  • Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof
    Publication number: 20050031647
    Abstract: The present invention relates to Lawsonia intracellularis vaccines and methods for protecting against and diagnosing L. intracellularis infection. The products and processes of the invention are attainable, in part, as the result of an improved method for cultivating large scale supplies of L. intracellularis, including both a novel isolate of L. intracellularis of European origin and a method of preparing a lyophilized product containing the attenuated European isolate as vaccine product.
    Type: Application
    Filed: July 15, 2004
    Publication date: February 10, 2005
    Applicant: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Michael Roof, Jeremy Kroll, Jeffrey Knittel